Omeros Releases Statement in Response to Recent False Report

07:00 EDT 29 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Omeros Corporation (NASDAQ: OMER) stated today that it is aware of a report posted on-line by “Art Doyle,” an entity or group that appears to be concealing its identity and is purportedly writing on behalf of itself or one o...

Other Sources for this Article

Cook Williams Communications, Inc.
Jennifer Cook Williams
Investor and Media Relations


More From BioPortfolio on "Omeros Releases Statement in Response to Recent False Report"

Quick Search


Relevant Topics

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...